Clinical Trial Update: Hemoglobin Kinetics in Response to Mircera® in Patients With Acute Myocardial Infarction [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating how Mircera affects hemoglobin kinetics in patients with acute myocardial infarction.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• MIRCERA (METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA)

Snippet

Sponsor: University Hospital, Basel, Switzerland | Conditions: Acute Myocardial Infarction | Phase 2 | Status: COMPLETED